000			05577nam a22006255i 4500
001			978-3-031-29882-0
003			DE-He213
005			20240207153626.0
007			cr nn 008mamaa
008			230628s2023 sz | s |||| 0|eng d
020			_a9783031298820 _9978-3-031-29882-0
050		4	_aQR74.8-99.5
072		7	_aPSG _2bicssc
072		7	_aSCI045000 _2bisacsh
072		7	_aPSG _2thema
082	0	4	_a579.3 _223
245	1	0	_aTrending Topics in Escherichia coli Research _h[electronic resource] : _bThe Latin American Perspective / _cedited by Alfredo G. Torres.
250			_a2nd ed. 2023.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2023.
300			_aXX, 363 p. 19 illus., 17 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
500			_aAcceso multiusuario
505	0		_aChapter 1. WHO Critical Priority Escherichia coli in Latin America: A One Health Challenge for a PostPandemic World -- Chapter 2. Recent progress on enterotoxigenic E. coli (ETEC) and antibiotic resistance in pathogenic E. coli -- Chapter 3. New concepts on domestic and wild reservoirs, and transmission of E. coli and its environment -- Chapter 4. New molecular mechanisms of virulence and pathogenesis in E. coli.-Chapter 5. Bovine reservoir of STEC and EPEC: advances and new contributions -- Chapter 6. Phages and Escherichia coli -- Chapter 7. Insights into animal carriage and pathogen surveillance in Latin America: the case of STEC and APEC -- Chapter 8. Shiga Toxin and its effect on the Central Nervous System -- Chapter 9. Relevance of Escherichia coli in fresh produce safety -- Chapter 10. Quantitative Microbial Risk Assessment of Hemolytic Uremic Syndrome due to Beef Consumption: Impact of Interventions to Reduce the Presence of Shiga Toxin-Producing Escherichia coli -- Chapter 11. An Updated Overview on the Resistance and Virulence of UPEC -- Chapter 12. Interactions of pathogenic Escherichia coli with gut microbiota -- Chapter 13. Emergence of Hybrid Escherichia coli Strains -- Chapter 14. Genomic analysis of pathogenic E. coli strains in Latin America -- Chapter 15. Therapeutic options for diarrheagenic Escherichia coli.
520			_aLatin America has been at the forefront in combating infections caused by Escherichia coli strains in humans, animals, and the environment. The continuous emergence and evolution of pathogenic E. coli strains associated with human and animal infections have demonstrated that (i) groups of related pathogenic E. coli are responsible for most infections caused by this bacterial species; (ii) diverse virulence phenotypes expressed during infection defined each one of these pathogroups; (iii) the geographical distribution of pathogroups in Latin America and the evolution of new isolates was defined by the dominant pathogroup and presence of distinct virulence strains; (iv) acquisition of mobile elements or accumulation of point mutations accelerate the development of antibiotic resistance in some of these strains. The Latin American Coalition for Escherichia coli Research (LACER), a multidisciplinary network of over seventy research groups in eleven Latin American countries and the USA, was established in 2009 to apply One Health principles in defining and combating this pathogen. The previous edition of this text, Escherichia coli in the Americas was the culmination of the investigators' wisdom about E. coli, from its role as a commensal bacterium to its characteristics as a pathogen. This new edition introduces recent advances and contextualizes all aspects of E. coli in a One Health perspective, from the environment, to animals, to humans. It addresses E. coli interactions with host microbiota, CNS, and phages, and includes cutting edge insights on hybrid strains, molecular mechanisms of virulence and pathogenesis, domestic and wild reservoirs, disease surveillance in Latin America, food safety, and new therapies. Crucially, it also presents translations and analysis of key reports on Escherichia coli published in Spanish and Portuguese. This book serves as a critical resource for scientists in industry and academia, clinicians managing associated infections, and trainees and students studying basic and clinical aspects of E. coli pathogenesis. .
541			_fUABC ; _cPerpetuidad
650		0	_aBacteria.
650		0	_aMedical microbiology.
650		0	_aMedicine _xResearch.
650		0	_aBiology _xResearch.
650		0	_aImmunology.
650		0	_aFood _xSafety measures.
650		0	_aTherapeutics.
650	1	4	_aBacteria.
650	2	4	_aMedical Microbiology.
650	2	4	_aBiomedical Research.
650	2	4	_aImmunology.
650	2	4	_aFood Safety.
650	2	4	_aTherapeutics.
700	1		_aTorres, Alfredo G. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
773	0		_tSpringer Nature eBook
776	0	8	_iPrinted edition: _z9783031298813
776	0	8	_iPrinted edition: _z9783031298837
776	0	8	_iPrinted edition: _z9783031303944
856	4	0	_zLibro electrónico _uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-3-031-29882-0
912			_aZDB-2-SBL
912			_aZDB-2-SXB
942			_cLIBRO_ELEC
999			_c261979 _d261978